常规治疗结合血府逐瘀汤治疗冠心病心绞痛发作的临床分析

摘要/Abstract

摘要： 目的观察常规治疗结合血府逐瘀汤对冠心病心绞痛发作患者的临床效果。方法选取2020年1月—2021年1月北大医疗鲁中医院收治的100例冠心病心绞痛患者,采用随机数表法分为对照组、观察组,每组50例。对照组予口服阿司匹林、阿托伐他汀治疗,观察组在对照组基础上联合血府逐瘀汤加减治疗,治疗期15 d。观察比较两组患者临床治疗有效率、心绞痛缓解时间、发作次数、住院时间、治疗满意度。结果观察组患者的治疗有效率显著优于对照组,差异有统计学意义（P<0.05）;观察组患者心绞痛缓解时间、发作次数、住院时间均少于对照组,差异有统计学意义（P<0.05）;观察组患者治疗满意度明显比对照组高,差异有统计学意义（P<0.05）。结论对于冠心病心绞痛发作患者,采用口服阿司匹林、阿托伐他汀联合血府逐瘀汤进行治疗,具有明显效果,可有效缓解患者临床症状,缩短患者心绞痛发作时间,减少发作次数,缩短住院时间,促进护患和谐相处,提升治疗有效率。

关键词: 冠心病, 心绞痛, 血府逐瘀汤, 疗效

Abstract: Objective To observe the clinical effect of routine treatment combined with oral Chinese herbal decoction in the treatment of coronary heart disease with angina pectoris. Methods From January 2020 to January 2021, 100 patients with coronary heart disease and angina pectoris were selected and treated in Luzhong Hospital of Peking University Medical College. They were randomly divided into control group and observation group with 50 patients in each group. The control group was treated with oral aspirin and atorvastatin, while the observation group was treated with Xuefu Zhuyu Decoction on the basis of the control group. The treatment period was 15 days. The clinical treatment efficiency, angina relief time, attack times, hospital stay, and treatment satisfaction between the two groups were observed and compared. Results The treatment response rate of patients in the observation group was significantly better than that of the control group, the difference between the two groups was significant differenc (P<0.05). Patients in the observation group had a shorter angina relief time and hospital stay than those in the control group, and all data were significantly different (P<0.05). The treatment satisfaction of patients in the observation group was significantly higher than that of the control group (P<0.05). Conclusion For patients with coronary heart disease and angina pectoris, the treatment of oral aspirin and atorvastatin combined with Xuefu Zhuyu Decoction has obvious effects, it can effectively relieve the clinical symptoms of patients, shorten the duration of angina pectoris, reduce the number of attacks, shorten the length of hospital stay, promote the harmonious coexistence of nurses and patients, and improve the efficiency of treatment.

Key words: coronary heart disease, angina pectoris, Xuefu Zhuyu Decoction, curative effect

中图分类号:

R541

王玉. 常规治疗结合血府逐瘀汤治疗冠心病心绞痛发作的临床分析[J]. 中华养生保健, 2023, 41(10): 29-31.

WANG Yu. Clinical Analysis of Routine Treatment Combined with Oral Chinese Herbal Decoction in the Treatment of Coronary Heart Disease with Angina Pectoris[J]. ZHONGHUA YANGSHENG BAOJIAN, 2023, 41(10): 29-31.

参考文献

[1] 金蕾,姬琛华,宓丹,等.舒心汤治疗冠心病心绞痛合并焦虑症临床疗效观察[J].辽宁中医药大学学报,2021,23(3):183-187.
[2] 郑英,台杰,刘俊娥.行气化瘀通痹针刺法联合三七丹茶治疗冠心病稳定型心绞痛(瘀血痹阻证)的临床观察[J].中国中医急症,2022,31(1):95-97.
[3] 李婷,钟超伶.温针灸与血府逐瘀汤联合常规疗法治疗冠心病心绞痛临床研究[J].新中医,2020,52(6):124-128.
[4] 桑珍珍. 盐酸川芎嗪注射液联合替格瑞洛治疗冠心病心绞痛的临床效果及心功能分析[J].中华养生保健,2021,39(10):165-167 .
[5] 袁志达. 中西医结合治疗冠心病心绞痛的疗效观察[J].内蒙古中医药,2020, 39(11): 50-51.
[6] 杨颖,黄秀华.益气养阴活血法治疗冠心病心绞痛的思考与探索[J].中国中医急症,2021,30(12):2133-2136.
[7] 刘佳,李杰,张书萌,等.稳心颗粒联合西医常规治疗冠心病心绞痛的Meta分析与GRADE评价[J].中国中医急症,2021,30(11):1881-1886,1896.
[8] 吴芳,宋榜林.中西医结合治疗冠心病稳定型心绞痛临床疗效观察[J].血栓与止血学,2021,27(4):566-568.
[9] 孙红娟,刘丽红.复方丹参滴丸结合西药治疗冠心病心绞痛的临床疗效[J].内蒙古中医药,2020,39(5):50-51.
[10] 杜玉苗,王秀玲.中西医联合治疗冠心病心绞痛——评《心脏病学实践2019》[J].中国国境卫生检疫杂志,2020,43(6):后插1.
[11] 周飞,徐海丽,任伟,等.通魂逆心汤治疗血瘀型冠心病稳定型心绞痛[J].中医学报,2020,35(8):1779-1783.
[12] 马腾,朱明军,王永霞,等.丹参注射液联合黄芪注射液治疗冠心病心绞痛疗效及安全性的系统评价[J].中西医结合心脑血管病杂志,2021,19(1):7-13.
[13] 杜中平,石可松.血府逐瘀汤配合针灸治疗冠心病心绞痛的疗效研究[J].中国全科医学,2021,24(S1):158-160.
[14] 谭万江. 辛伐他汀联合生脉散合血府逐瘀汤治疗冠心病的疗效分析[J].中国现代应用药学,2020,37(4):478-482.
[15] 侯莉,于颖,周淑妮,等.血府逐瘀汤加减联合西药治疗高血压合并冠心病的疗效观察[J].世界中西医结合杂志,2021,16(9):1714-1718.
[16] 刘新锋,关玲霞.血府逐瘀汤联合西药治疗冠心病不稳定型心绞痛临床研究[J].新中医,2021,53(19):56-60.
[17] WANG B, TENG Y, LI Y, et al.Evidence and Characteristics of Traditional Chinese Medicine for Coronary Heart Disease Patients With Anxiety or Depression: A Meta-Analysis and Systematic Review[J]. Front Pharmacol,2022,13:854292.
[18] FAN M, GUO D, WANG Y, et al.Efficacy and safety of Xinkeshu in the treatment of angina pectoris of coronary heart disease: A protocol for systematic review and meta-analysis[J]. Medicine (Baltimore),2021,100(40):e27407.
[19] CHEN W, WANG B, GE Y, et al.A systematic review and meta-analysis of clinical research on treating angina pectoris of coronary heart disease with traditional Chinese medicine to promote blood circulation and remove blood stasis[J]. Ann Palliat Med,2021,10(10):10506-10514.
[20] CHEN Y, XIAO X, XU X, et al.Traditional Chinese Medicine in the prevention and treatment of stable angina pectoris in patients with coronary heart disease based on the theory of “phlegm and blood stasis” under guidance of evidence-based medicine: a prospective cohort study[J]. J Tradit Chin Med,2021,41(1):150-156.